University of Oxford to launch Pandemic Sciences Centre

The University of Oxford has announced the launch of a new centre of global research collaboration and excellence, the Pandemic Sciences Centre. Its mission will be to ensure that the world is better equipped to create global, and equitable science-driven solutions to prepare for, identify, and counter future pandemic threats.

The Pandemic Sciences Centre, which will include a number of core institutes, will harness the strong global research collaborations that the University of Oxford has developed over more than forty years. It will also build on the strong and unique collaborations developed in record time across national borders between academia, industry and public health bodies during the coronavirus pandemic.

Within Oxford, the centre will draw together academics and experts from across its research and innovation community, including from infectious diseases, vaccinology, immunology, structural biology, diagnostics, drug discovery, clinical trials, data science, public health, and social and political sciences. Nationally and internationally, the centre will foster a multisectoral approach and invest in agile platforms and partnerships.

The centre will focus on three core themes: Accelerating understanding and insights; translating research into real-world solutions: creating and deploying effective, acceptable and equitable health technologies; and enhancing confidence, trust and impact.

Professor Sir John Bell, Regius Professor of Medicine at Oxford University, said: “It would be easy to ignore just how much more serious a pandemic could have been this time around – other highly pathogenic viruses carry mortalities of 35-50% – imagine if we had a pandemic where one in three infected people died. The University of Oxford is uniquely capable of leading a global step change in how we respond to the threat of emerging infections. By investing in sound science now, we can help to safeguard our resilience, global economic stability and health security for generations to come. We are ready to take our vision to build on these foundations to ensure society is better prepared and agile in its response to future threats.”

The inaugural Director of the centre will be Peter Horby, Professor of Emerging Infectious Diseases at the University of Oxford, who has worked on many global health threats including SARS-1, bird flu, Middle East Respiratory Syndrome, Ebola, Lassa fever, and plague. He said: “The Covid-19 pandemic has shown us that spectacular advances are possible through an alliance of science, the public sector and industry – creating digital disease control tools, diagnostic tests, and life-saving treatments and vaccines at unprecedented speed. But it should not take a pandemic to make this happen. This level of innovation and multi-sectoral collaboration must be applied, day in and day out, to prevent another catastrophe like Covid-19.’

The next few months will see significant activity to support the Centre’s development as the University looks to secure over £500 million to invest in this centre – with contributions from philanthropists, corporate partners and governments.

Image credit: Sidharth Bhatia

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free